Effect of pH and formulation variables on in vitro transcorneal permeability of flurbiprofen: A technical note

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 1031-1037

  Chandran, Sajeev ^a   Roy, Archna ^a   Saha, Ranendra N ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Flurbiprofen; Goat cornea; Transcorneal permeability

Indexed keywords

BENZALKONIUM CHLORIDE; BENZYL ALCOHOL; CHLORBUTOL; DRUG ADDITIVE; EDETIC ACID; EYE DROPS; FLURBIPROFEN; METHYL PARABEN; OCUFLUR; PHENYLMERCURIC NITRATE; PHOSPHATE; POLYMER; PROPYL PARABEN; THIOMERSAL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; GOAT; IN VITRO STUDY; NONHUMAN; PH;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CORNEA; FLURBIPROFEN; GOATS; HYDROGEN-ION CONCENTRATION; PERMEABILITY;

EID: 57149124350     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9139-4     Document Type: Article

References (27)

1. T. F. Patton, and J. R. Robinson. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. J. Pharm. Sci. 65(9):1295-1301 (1976).
2. D. D. Tang-Liu, S. S. Liu, and R. J. Weinkam. Ocular and systemic bioavailability of ophthalmic flurbiprofen. J. Pharmacokinet. Biopharm. 12(6):611-626 (1984).
3. C. H. Chiang, and R. D. Schoenwald. Ocular pharmacokinetic models of clonidine-3H hydrochloride. J. Pharmacokinet. Biopharm. 14 (2):175-211 (1986).
4. R. D. Schoenwald, and H. S. Huang. Corneal penetration behavior of beta-blocking agents I: Physiochemical factors. J. Pharm. Sci. 72(11):1266-1272 (1983).
5. W. Wang, H. Sasaki, D. S. Chien, and V. H. Lee. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: A comparison with corneal penetration. Curr. Eye Res. 10(6):571-579 (1991).
6. N. Ehlers. Morphology and histochemistry of the corneal epithelium of mammals. Acta Anat. (Basel). 75(2):161-198 (1970).
7. L. Z. Bito. Species differences in the responses of the eye to irritation and trauma: A hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research. Exp. Eye Res. 39(6):807-829 (1984).
8. O. Reer, T. K. Bock, and B. W. Muller. In vitro corneal permeability of diclofenac sodium in formulations containing cyclodextrins compared to the commercial product voltaren ophtha. J. Pharm. Sci. 83(9):1345-1349 (1994).
9. M. Malhotra, and D. K. Majumdar. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops. Indian J. Exp. Biol. 35(9):941-947 (1997).
10. M. Malhotra, and D. K. Majumdar. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment. Indian J. Exp. Biol. 35(9):1324-1330 (1997).
11. M. Gupta, and D. K. Majumdar. Effect of concentration, pH, and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops. Indian J. Exp. Biol. 35(8):844-849 (1997).
12. R. C. Fu, and D. M. Lidgate. In vitro rabbit corneal permeability study of ketorolac tromethamine. Drug Dev. Ind. Pharm. 12: 2403-2430 (1986).
13. C. Sajeev, P. R. Jadhav, P. B. Kharwade, and R. N. Saha. Rapid and sensitive spectrofluorimetric method for the estimation of celecoxib and flurbiprofen. Indian J. Pharm. Sci. 68(1):20-25 (2006).
14. C. Sajeev, P. R. Jadhav, D. Ravishanker, and R. N. Saha. Determination of flurbiprofen in pharmaceutical dosage form by UV spectrophotometry and LC. Anal. Chim. Acta. 463(2):207-217 (2002).
15. G. Gomori. In S. P. Colowick, and N. O. Kaplan (eds.), Methods in Enzymology I, Academic Press, NewYork, 1955, p. 145.
16. O. Camber. An in vitro model for determination of drug permeability through the cornea. Acta Pharm. Suec. 22: 335-342 (1985).
17. S. Bolton. Pharmaceutical statistics: Practical and Clinical Application, 3rd ed., Marcel Dekker, New York, 1997, pp. 153-216.
18. N. L. Burstein, and S. D. Klyce. Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium. Invest. Ophthalmol. Vis. Sci. 16(10):899-911 (1977).
19. P. N. Craig. In C. Hansch, P. G. Sammes, and J. B. Taylor (eds.), Comprehensive Medicinal Chemistry Vol 6, Pergamon, Oxford, 1990, p. 541.
20. Y. Rojanasakul, and J. R. Robinson. Transport mechanisms of the cornea: characterization of barrier permselectivity. Int. J. Pharm. 55: 237-246 (1989).
21. D. L. van Horn, H. F. Edelhauser, G. Prodanovich, R. Eiferman, and H. F. Pederson. Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium. Invest. Ophthalmol. Vis. Sci. 16(4):273-280 (1977).
22. A. R. Gasset, Y. Ishii, H. E. Kaufman, and T. Miller. Cytotoxicity of ophthalmic preservatives. Am. J. Ophthalmol. 78(1):98-105 (1974).
23. P. K. Pawar, and D. K. Majumdar. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous solutions through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech. 7(1):E13 (2006).
24. M. R. Singh, and D. K. Majumdar. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech. 7(3):E57 (2006).
25. Y. Rojanasakul, J. Liaw, and J. R. Robinson. Mechanism of action of some penetration enhancers in the cornea: Laser scanning confocal microscopic and electrophysiology studies. Int. J. Pharm. 66: 131-142 (1990).
26. G. M. Grass, R. W. Wood, and J. R. Robinson. Effects of calcium chelating agents on corneal permeability. Invest. Ophthalmol. Vis. Sci. 26: 110-113 (1985).
27. D. M. Maurice, and M. V. Riley. In C. N. Graymore (ed.), Biochemistry of Eye, Academic, NewYork, 1970, p. 381.